First Evidence of Polymorphism in Furosemide Solvates

Beloborodova, Alina A.; Minkov, V. S.; Rychkov, Denis A.; Rybalova, Tatyana V.; Boldyreva, Elena V.

doi:10.1021/acs.cgd.6b01191

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

First Evidence of Polymorphism in Furosemide Solvates

MPS-Authors

/persons/resource/persons203187

Minkov, V. S.
High Pressure Group, Max Planck Institute for Chemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Beloborodova, A. A., Minkov, V. S., Rychkov, D. A., Rybalova, T. V., & Boldyreva, E. V. (2017). First Evidence of Polymorphism in Furosemide Solvates. Crystal Growth & Design, 17(5), 2333-2341. doi:10.1021/acs.cgd.6b01191.

引用: https://hdl.handle.net/11858/00-001M-0000-002D-9832-D

要旨

Several polymorphs of solvates of furosemide with dimethyl sulfoxide (DMSO) and dimethylformamide (DMF) have been obtained, and their crystal structures were solved and analyzed. The structures differ from each other in both conformation of the furosemide molecule (particularly with respect to the orientation of the furanylmethylamino fragment) and molecular packing. The arrangement of solvent molecules—DMSO and DMF—is different in different polymorphs: either in the channels or between the layers. Layered polymorphs can be formed on rapid crystallization using water as an antisolvent, whereas a slower crystallization on evaporation promotes the growth of channeled structures. Despite different crystal structures, F-DMSO-I, F-DMSO-II, F-DMSO-III, and F-DMF-II give the same phase on desolvation, namely, furosemide polymorph I, which is the thermodynamic form at ambient conditions.